1. 4CPS-143 Evaluation of knowledge of patients with inflammatory bowel disease treated by the reference product concerning biosimilars: role of clinical pharmacists. (March 2019) Authors: Coget, E; Laffont-Lozes, P; Velasco Gonzalvo, V; Huc, D; Pineton de Chambrun, G; Altwegg, R; Blanc, P; Pageaux, GP; Rosant, D; Breuker, C Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-144 Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease. (March 2019) Authors: Coget, E; Laffont-Lozes, P; Velasco Gonzalvo, V; Huc, D; Pineton de Chambrun, G; Altwegg, R; Blanc, P; Pageaux, GP; Rosant, D; Breuker, C Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID. (12th December 2020) Authors: Buisson, A; Filippi, J; Amiot, A; Cadiot, G; Allez, M; Marteau, P; Bouhnik, Y; Pineton de Chambrun, G; Pelletier, A L; Nancey, S; Moussata, D; Attar, A; Blain, A; Vuitton, L; Vernier-Massouille, G; Seksik, P; Nachury, M; Dupas, J L; Laharie, D; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 6(2021) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP029 Treatment and long-term outcomes of paediatric patients with penetrating Crohn's disease. (16th January 2018) Authors: Kollen, L; Leroyer, A; Breton, A; Fumery, M; Savoye, G; Lemale, J; Morin, D; Pariente, B; Mas, E; Turck, D; Al Khouri, M; Blanc, P; Gower, C; Pineton de Chambrun, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP63 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP74 Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Bouhnik, Y; Amiot, A; Viennot, S; Serrero, M; Fumery, M; Allez, M; Siproudhis, L; Buisson, A; Pineton de Chambrun, G; Abitbol, V; Nancey, S; Caillo, L; Plastaras, L; Armengol-Debeir, L; Chanteloup, E; Simon, M; Dib, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti-α4 integrin therapy?. Issue 11 (21st October 2008) Authors: Pineton de Chambrun, G; Vernier-Massouille, G; Viget, N; Colombel, J-F; Yazdanpanah, Y Journal: Gut Issue: Volume 57:Issue 11(2008) Page Start: 1633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P286 Bariatric surgery in inflammatory bowel disease: outcome and safety from a GETAID registry population. (25th January 2019) Authors: Reenaers, C; Nachury, M; Stefanescu, C; Pineton de Chambrun, G; Laharie, D; Boileve, J; Viennot, S; Peyrin-Biroulet, L; Roblin, X; Grimaud, J-C; Bouguen, G; Nahon, S; Goutorbe, F; Coffin, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P369 Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study. (16th January 2018) Authors: Streichenberger, A; Pariente, B; Bozon, A; Arab, N; Amiot, A; Vuitton, L; Tilmant, M; Nachury, M; Altwegg, R; Delasalle, T; Gagnière, C; Grégoire, B; Fumery, M; Wils, P; Pineton de Chambrun, G; Hébuterne, X; Pereira, B; Bommelaer, G; Buisson, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗